| Gene symbol | CCNG1 | Synonyms | CCNG | Type of gene | protein-coding |
| Chromosome | 5 | Map location | 5q34 | dbXrefs | |
| Description | cyclin G1 | ||||
| GTO ID | GTC1273 |
| Trial ID | NCT00505271 |
| Disease | Breast Cancer |
| Altered gene | CCNG1 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | Rexin-G |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | Phase I/II Evaluation of Safety and Efficacy of Pathotropic Nanoparticles Bearing a Dominant Negative Cyclin G1 Construct (Rexin-G) as Intervention for Recurrent or Metastatic Breast Cancer |
| Year | 2007 |
| Country | United States |
| Company sponsor | Epeius Biotechnologies |
| Other ID(s) | C07-104 |
| Vector information | |||
|
|||
| Cohort 1 | |||||
|
|||||